Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Prevention02:59

Cancer Prevention

7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.6K
Cancer Vaccines01:30

Cancer Vaccines

945
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
945
Cancer02:18

Cancer

53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.8K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.8K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.9K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

In Response to Longitudinal Analysis of Oral Potentially Malignant Disorder Conversion to Malignancy.

The Laryngoscope·2026
Same author

Longitudinal Analysis of Oral Potentially Malignant Disorder Conversion to Malignancy.

The Laryngoscope·2025
Same author

Evidence-Based Lung Cancer Screening in a Tailored Package.

Cancer prevention research (Philadelphia, Pa.)·2025
Same author

NCI Resources for Cancer Immunoprevention Research.

Cancer immunology research·2024
Same author

Primary Prevention and Interception Studies in RAS-Mutated Tumor Models Employing Small Molecules or Vaccines.

Cancer prevention research (Philadelphia, Pa.)·2023
Same author

Emerging Trends in Cancer Prevention Agent Development.

Journal of cancer prevention·2023
Same journal

Optimization of RNA Sequencing Workflow in Brush Swabs of Oral Squamous Cell Carcinoma.

Cancer prevention research (Philadelphia, Pa.)·2026
Same journal

Proteomic analysis of sphingolipid metabolic enzymes with risk of bladder cancer incidence and mortality in the Atherosclerosis Risk in Communities (ARIC) Study.

Cancer prevention research (Philadelphia, Pa.)·2026
Same journal

Cancer Screening Adherence in the US by Smoking and Vaping Status, 2023.

Cancer prevention research (Philadelphia, Pa.)·2026
Same journal

Advancing Gastric Cancer Chemoprevention: Early Signals and Ongoing Challenges.

Cancer prevention research (Philadelphia, Pa.)·2026
Same journal

Will they use it? Patient and provider acceptance of chatbot screening and counseling for hereditary cancer syndromes in a geographically underserved population.

Cancer prevention research (Philadelphia, Pa.)·2026
Same journal

The Clinical Application of Refined Risk Estimates (caRe) Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial.

Cancer prevention research (Philadelphia, Pa.)·2026
查看所有相关文章

相关实验视频

Updated: Jan 12, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.1K

癌症预防/拦截代理开发开发

Mark Steven Miller1, Frank G Ondrey2

  • 1CancerTox Consulting, Greensboro, North Carolina.

Cancer prevention research (Philadelphia, Pa.)
|November 3, 2025
PubMed
概括
此摘要是机器生成的。

开发有效的癌症预防剂需要识别高风险人群并优化药物输送. 未来的战略将将疫苗与化疗/免疫预防剂结合起来,以减少癌症死亡率.

更多相关视频

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.8K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.3K

相关实验视频

Last Updated: Jan 12, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.1K
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.8K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.3K

科学领域:

  • 在瘤学瘤学.
  • 预防医学 预防医学
  • 药物开发 药物开发

背景情况:

  • 尽管经过数十年的研究,癌症预防/拦截剂的临床使用有限.
  • 了解早期癌症和癌前病变的进展为改善预防策略提供了机会.

研究的目的:

  • 为推进癌症预防和拦截剂概述关键考虑因素.
  • 强调需要在药剂开发和临床翻译方面改进方法.

主要方法:

  • 识别高风险人群和相关的分子标.
  • 使用精确的动物模型,用于早期人类病变.
  • 评估剂的生理化学性质,毒性,溶解性和器官积累.
  • 评估健康,高风险个体的长期耐受性.

主要成果:

  • 在模型中,保证剂显示出显著的瘤发育减少 (≥50%).
  • 考虑策略来最大限度地减少副作用,如组合疗法和替代性输送系统.
  • 强调早期行业合作对于临床试验进展的重要性.

结论:

  • 癌症预防和拦截需要采用多方面的方法,将强大的临床前验证与临床开发相结合.
  • 未来的努力可能涉及组合疗法,包括疫苗和化疗/免疫预防剂,以提高疗效和降低癌症死亡率.